Authors:
MONIG H
PETER M
PARTSCH CJ
KLOEHN S
ARENDT T
SIPPELL WG
Citation: H. Monig et al., CLINICAL DETERIORATION AFTER CESSATION OF GROWTH-HORMONE REPLACEMENT THERAPY IN A YOUNG-ADULT WITH SEVERE GROWTH-HORMONE DEFICIENCY, Growth hormone & IGF research, 8(5), 1998, pp. 385-387
Authors:
ARENDT T
NIZZE H
STUBER E
MONIG H
KLOEHN S
FOLSCH UR
Citation: T. Arendt et al., INFECTED BILE-INDUCED ACUTE-PANCREATITIS IN RABBITS - THE ROLE OF BACTERIA, International journal of pancreatology, 24(2), 1998, pp. 111-116
Authors:
KLOEHN S
ARENDT T
REINECKELUTHGE A
KLOMP HJ
MONIG H
Citation: S. Kloehn et al., CUSHING-SYNDROME WITH LIFE-THREATENING IN FECTIOUS COMPLICATIONS, Deutsche Medizinische Wochenschrift, 122(50), 1997, pp. 1547-1552
Authors:
KIEHNE K
KLOEHN S
HINRICHSEN H
GALLWITZ B
MONIG H
Citation: K. Kiehne et al., THYROID AUTOANTIBODIES AND THYROID-DYSFUNCTION DURING TREATMENT WITH INTERFERON-ALPHA FOR CHRONIC HEPATITIS-C, Endocrine, 6(3), 1997, pp. 231-234
Authors:
ARENDT T
STOFFREGEN C
KLOEHN S
MONIG H
NIZZE H
FOLSCH UR
Citation: T. Arendt et al., SANTORINIS DUCT - RISK FACTOR FOR ACUTE-PANCREATITIS OR PROTECTIVE MORPHOLOGIC VARIANT - EXPERIMENTS IN RABBITS, European journal of gastroenterology & hepatology, 9(6), 1997, pp. 569-573
Authors:
BRENNER W
HAUSCHILD A
ENGEL G
BOHUSLAVIZKI KH
MONIG H
CHRISTOPHERS E
HENZE E
Citation: W. Brenner et al., S100 IRMA - A NEW AND PROGNOSTIC TUMOR-MARKER IN PATIENTS WITH MALIGNANT-MELANOMA, The Journal of nuclear medicine, 38(5), 1997, pp. 600-600
Authors:
KARL M
VONWICHERT G
KEMPTER E
KATZ DA
REINCKE M
MONIG H
ALI IU
STRATAKIS CA
OLDFIELD EH
CHROUSOS GP
SCHULTE HM
Citation: M. Karl et al., NELSONS SYNDROME-ASSOCIATED WITH A SOMATIC FRAME-SHIFT MUTATION IN THE GLUCOCORTICOID RECEPTOR GENE, The Journal of clinical endocrinology and metabolism, 81(1), 1996, pp. 124-129
Authors:
BAMBERGER CM
MONIG H
MILL G
GODDE E
SCHULTE HM
Citation: Cm. Bamberger et al., GROWTH-HORMONE SECRETION IN RESPONSE TO THE NEW CENTRALLY ACTING ANTIHYPERTENSIVE AGENT MOXONIDINE IN NORMAL HUMAN-SUBJECTS - COMPARISON TOCLONIDINE AND GHRH, EXPERIMENTAL AND CLINICAL ENDOCRINOLOGY & DIABETES, 103(3), 1995, pp. 205-208
Authors:
BOHUSLAVIZKI KH
OBERWOHRMANN S
BRENNER W
EBERHARDT JU
MONIG H
CLAUSEN M
SIPPEL C
WOLF H
EPE B
HENZE E
Citation: Kh. Bohuslavizki et al., IN-111-OCTREOTIDE IMAGING IN PATIENTS WITH LONG-STANDING GRAVES OPHTHALMOPATHY, Nuclear medicine communications, 16(11), 1995, pp. 912-916
Citation: H. Monig et al., HYPOCALCEMIC CARDIOMYOPATHY AS A CAUSE OF SEVERE LEFT-VENTRICULAR FAILURE, Deutsche Medizinische Wochenschrift, 119(38), 1994, pp. 1270-1275
Citation: H. Monig et al., SUPPRESSED THYROID-STIMULATING HORMONE-SECRETION IN PATIENTS TREATED WITH INTERLEUKIN-2 AND INTERFERON-ALPHA(2B) FOR METASTATIC MELANOMA, The Clinical investigator, 72(12), 1994, pp. 975-978
Citation: Hm. Schulte et H. Monig, HORMONE MEASUREMENT IN BLOOD FROM INFERIOR PETROSAL SINUS - CLINICAL AND EXPERIMENTAL IMPLICATIONS, Journal of endocrinological investigation, 16(8), 1993, pp. 647-653
Citation: H. Monig et al., STRUCTURE OF THE POMC PROMOTER REGION IN PITUITARY AND EXTRAPITUITARYACTH PRODUCING TUMORS, Experimental and clinical endocrinology, 101(1), 1993, pp. 36-38